Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events.
Cancers (Basel)
; 9(7)2017 Jun 26.
Article
en En
| MEDLINE
| ID: mdl-28672850
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Idioma:
En
Revista:
Cancers (Basel)
Año:
2017
Tipo del documento:
Article
País de afiliación:
Estados Unidos